BI
LGND icon

BVF Inc’s Ligand Pharmaceuticals LGND Stock Holding History

BVF Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-428,145
Closed -$20.6M – 32
2015
Q1 		$20.6M Sell
428,145
-950,536
-69% -$36.4M 4.31% 8
2014
Q4 		$45.8M Sell
1,378,681
-398,666
-22% -$13M 8.9% 4
2014
Q3 		$52.1M Sell
1,777,347
-1,257,329
-41% -$41.7M 10.82% 3
2014
Q2 		$118M Sell
3,034,676
-325,879
-10% -$13.2M 18.65% 2
2014
Q1 		$141M Sell
3,360,555
-849,179
-20% -$35.4M 21.86% 1
2013
Q4 		$138M Sell
4,209,734
-845,591
-17% -$27.6M 24.17% 1
2013
Q3 		$136M Sell
5,055,325
-750,204
-13% -$21.1M 23.48% 1
2013
Q2 		$136M Buy
+5,805,529
New +$104M 26.3% 1

Other funds holding LGND

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc's LGND Position: Q2 2015 in Review

BVF Inc sold out of Ligand Pharmaceuticals (LGND) in Q2 2015, closing a stake of 428,145 shares — an estimated $20.6M sold.

BVF Inc first reported a position in LGND in Q2 2013 and held it in 8 quarters. The position peaked at $141M in Q1 2014. 215 funds tracked by Wall St. Rank hold LGND as of Q2 2015.

  • BVF Inc reported no remaining Ligand Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • BVF Inc sold 428,145 Ligand Pharmaceuticals shares in Q2 2015, an estimated $20.6M.
  • BVF Inc first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • BVF Inc's Ligand Pharmaceuticals position peaked at $141M in Q1 2014.
  • 215 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2015.

Based on BVF Inc's 13F filing for Q2 2015, filed 14 Aug 2015.